{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:40:34Z","timestamp":1790775634189,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.autrev.2016.02.020","type":"journal-article","created":{"date-parts":[[2016,2,26]],"date-time":"2016-02-26T08:20:15Z","timestamp":1456474815000},"page":"649-655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Th9 lymphocytes: A recent history from IL-9 to its potential role in rheumatic diseases"],"prefix":"10.1016","volume":"15","author":[{"given":"Wilmer Gerardo","family":"Rojas-Zuleta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"V\u00e1squez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.autrev.2016.02.020_bb0005","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.136.7.2348","article-title":"Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins","volume":"136","author":"Mosmann","year":"1986","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.autrev.2016.02.020_bb0010","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/eji.1830200813","article-title":"Establishment of different T cell sublines using either interleukin 2 or interleukin 4 as growth factors","volume":"20","author":"Schmitt","year":"1990","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2016.02.020_bb0015","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","article-title":"Differentiation of effector CD4 T cell populations (*)","volume":"28","author":"Zhu","year":"2010","journal-title":"Annu Rev Immunol"},{"issue":"5107","key":"10.1016\/j.autrev.2016.02.020_bb0020","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1126\/science.8097338","article-title":"Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages","volume":"260","author":"Hsieh","year":"1993","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.autrev.2016.02.020_bb0025","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1084\/jem.172.3.921","article-title":"Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells","volume":"172","author":"Le Gros","year":"1990","journal-title":"J Exp Med"},{"issue":"5969","key":"10.1016\/j.autrev.2016.02.020_bb0030","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1178334","article-title":"Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells","volume":"327","author":"O'Shea","year":"2010","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.autrev.2016.02.020_bb0035","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1084\/jem.20091442","article-title":"Nine lives: plasticity among T helper cell subsets","volume":"206","author":"Locksley","year":"2009","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.autrev.2016.02.020_bb0040","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.coi.2012.02.001","article-title":"The symphony of the ninth: the development and function of Th9 cells","volume":"24","author":"Jabeen","year":"2012","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2016.02.020_bb0045","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1084\/jem.169.1.363","article-title":"Cloning and characterization of a cDNA for a new mouse T cell growth factor (P40)","volume":"169","author":"Van Snick","year":"1989","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.autrev.2016.02.020_bb0050","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1002\/eji.1830191130","article-title":"TCGF III\/P40 is produced by naive murine CD4+ T cells but is not a general T cell growth factor","volume":"19","author":"Schmitt","year":"1989","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2016.02.020_bb0055","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1749-6632.2011.06351.x","article-title":"From interleukin-9 to T helper 9 cells","volume":"1247","author":"Stassen","year":"2012","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"10.1016\/j.autrev.2016.02.020_bb0060","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.4049\/jimmunol.153.9.3989","article-title":"IL-9 production of naive CD4+ T cells depends on IL-2, is synergistically enhanced by a combination of TGF-beta and IL-4, and is inhibited by IFN-gamma","volume":"153","author":"Schmitt","year":"1994","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.autrev.2016.02.020_bb0065","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ni.1659","article-title":"Transforming growth factor-beta \u2018reprograms\u2019 the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset","volume":"9","author":"Veldhoen","year":"2008","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2016.02.020_bb0070","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0092-8674(00)80702-3","article-title":"A novel transcription factor, T-bet, directs Th1 lineage commitment","volume":"100","author":"Szabo","year":"2000","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.autrev.2016.02.020_bb0075","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0092-8674(00)80240-8","article-title":"The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells","volume":"89","author":"Zheng","year":"1997","journal-title":"Cell"},{"issue":"5609","key":"10.1016\/j.autrev.2016.02.020_bb0080","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.autrev.2016.02.020_bb0085","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.autrev.2016.02.020_bb0090","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/ni.1677","article-title":"IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(\u2212) effector T cells","volume":"9","author":"Dardalhon","year":"2008","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2016.02.020_bb0095","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.immuni.2010.07.014","article-title":"Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells","volume":"33","author":"Staudt","year":"2010","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.autrev.2016.02.020_bb0100","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/ni.1867","article-title":"The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation","volume":"11","author":"Chang","year":"2010","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2016.02.020_bb0105","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/icb.2010.53","article-title":"Regulation of human Th9 differentiation by type I interferons and IL-21","volume":"88","author":"Wong","year":"2010","journal-title":"Immunol Cell Biol"},{"issue":"4","key":"10.1016\/j.autrev.2016.02.020_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2011.12.965","article-title":"Activin A and TGF-beta promote T(H)9 cell-mediated pulmonary allergic pathology","volume":"129","author":"Jones","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2016.02.020_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2011.06.019","article-title":"Predisposition to the development of IL-9-secreting T cells in atopic infants","volume":"128","author":"Yao","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.autrev.2016.02.020_bb0120","doi-asserted-by":"crossref","first-page":"6795","DOI":"10.4049\/jimmunol.1001676","article-title":"Antigen-specific Th9 cells exhibit uniqueness in their kinetics of cytokine production and short retention at the inflammatory site","volume":"185","author":"Tan","year":"2010","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2016.02.020_bb0125","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0092-8674(94)90335-2","article-title":"Signals and signs for lymphocyte responses","volume":"76","author":"Janeway","year":"1994","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.autrev.2016.02.020_bb0130","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ni.2390","article-title":"OX40 signaling favors the induction of T(H)9 cells and airway inflammation","volume":"13","author":"Xiao","year":"2012","journal-title":"Nat Immunol"},{"issue":"11","key":"10.1016\/j.autrev.2016.02.020_bb0135","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.2217\/imt.11.126","article-title":"Notch and inflammatory T cell response: new developments and challenges","volume":"3","author":"Mochizuki","year":"2011","journal-title":"Immunotherapy"},{"issue":"4","key":"10.1016\/j.autrev.2016.02.020_bb0140","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.immuni.2012.01.020","article-title":"Notch receptors and Smad3 signaling cooperate in the induction of interleukin-9-producing T cells","volume":"36","author":"Elyaman","year":"2012","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.autrev.2016.02.020_bb0145","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/ni.1846","article-title":"Regulation of IL-9 expression by IL-25 signaling","volume":"11","author":"Angkasekwinai","year":"2010","journal-title":"Nat Immunol"},{"issue":"8","key":"10.1016\/j.autrev.2016.02.020_bb0150","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.4049\/jimmunol.1203102","article-title":"Calcitonin gene-related peptide and cyclic adenosine 5\u2032-monophosphate\/protein kinase A pathway promote IL-9 production in Th9 differentiation process","volume":"190","author":"Mikami","year":"2013","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2016.02.020_bb0155","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.immuni.2013.01.007","article-title":"Interleukin-9 is required for allergic airway inflammation mediated by the cytokine TSLP","volume":"38","author":"Yao","year":"2013","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.autrev.2016.02.020_bb0160","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/imr.12028","article-title":"Th9 cells: differentiation and disease","volume":"252","author":"Kaplan","year":"2013","journal-title":"Immunol Rev"},{"issue":"9","key":"10.1016\/j.autrev.2016.02.020_bb0165","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1073\/pnas.1301138111","article-title":"Opposing actions of IL-2 and IL-21 on Th9 differentiation correlate with their differential regulation of BCL6 expression","volume":"111","author":"Liao","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.autrev.2016.02.020_bb0170","doi-asserted-by":"crossref","first-page":"968","DOI":"10.4049\/jimmunol.1102840","article-title":"STAT6-dependent regulation of Th9 development","volume":"188","author":"Goswami","year":"2012","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2016.02.020_bb0175","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.immuni.2005.03.016","article-title":"PU.1 expression delineates heterogeneity in primary Th2 cells","volume":"22","author":"Chang","year":"2005","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.autrev.2016.02.020_bb0180","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.4049\/jimmunol.1201496","article-title":"Gcn5 is required for PU.1-dependent IL-9 induction in Th9 cells","volume":"189","author":"Goswami","year":"2012","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.autrev.2016.02.020_bb0185","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1172\/JCI69489","article-title":"Th9 cell development requires a BATF-regulated transcriptional network","volume":"123","author":"Jabeen","year":"2013","journal-title":"J Clin Invest"},{"issue":"19","key":"10.1016\/j.autrev.2016.02.020_bb0190","doi-asserted-by":"crossref","first-page":"15445","DOI":"10.1074\/jbc.M112.340356","article-title":"Nuclear factor of activated T cells 1 (NFAT1)-induced permissive chromatin modification facilitates nuclear factor-kappaB (NF-kappaB)-mediated interleukin-9 (IL-9) transactivation","volume":"287","author":"Jash","year":"2012","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.autrev.2016.02.020_bb0195","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nri2848","article-title":"Cellular sources and immune functions of interleukin-9","volume":"10","author":"Noelle","year":"2010","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2016.02.020_bb0200","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/1043-4666(90)90037-T","article-title":"Cloning and expression of a cDNA for the human homolog of mouse T cell and mast cell growth factor P40","volume":"2","author":"Renauld","year":"1990","journal-title":"Cytokine"},{"issue":"24","key":"10.1016\/j.autrev.2016.02.020_bb0205","doi-asserted-by":"crossref","first-page":"13175","DOI":"10.1073\/pnas.94.24.13175","article-title":"Interleukin 9: a candidate gene for asthma","volume":"94","author":"Nicolaides","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.autrev.2016.02.020_bb0210","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.it.2011.01.006","article-title":"Regulating IL-9 transcription in T helper cells","volume":"32","author":"Perumal","year":"2011","journal-title":"Trends Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2016.02.020_bb0215","first-page":"243","article-title":"Signalling by cytokines interacting with the interleukin-2 receptor gamma chain","volume":"4","author":"Demoulin","year":"1998","journal-title":"Cytokines Cell Mol Ther"},{"issue":"4","key":"10.1016\/j.autrev.2016.02.020_bb0220","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/08977190410001720879","article-title":"IL-9 and its receptor: from signal transduction to tumorigenesis","volume":"22","author":"Knoops","year":"2004","journal-title":"Growth Factors"},{"issue":"7","key":"10.1016\/j.autrev.2016.02.020_bb0225","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.4049\/jimmunol.150.7.2634","article-title":"Human T cell lines and clones respond to IL-9","volume":"150","author":"Houssiau","year":"1993","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2016.02.020_bb0230","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/eji.1830200632","article-title":"Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40\/TCGFIII (interleukin 9)","volume":"20","author":"Hultner","year":"1990","journal-title":"Eur J Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2016.02.020_bb0235","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1182\/blood.V74.6.1880.1880","article-title":"Expression cloning of cDNA encoding a novel human hematopoietic growth factor: human homologue of murine T-cell growth factor P40","volume":"74","author":"Yang","year":"1989","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.autrev.2016.02.020_bb0240","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/intimm\/dxt039","article-title":"IL-9 and Th9 cells: progress and challenges","volume":"25","author":"Zhao","year":"2013","journal-title":"Int Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2016.02.020_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/intimm\/dxl117","article-title":"IL9 leads to airway inflammation by inducing IL13 expression in airway epithelial cells","volume":"19","author":"Temann","year":"2007","journal-title":"Int Immunol"},{"issue":"7","key":"10.1016\/j.autrev.2016.02.020_bb0250","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/eji.1830230743","article-title":"Interleukin-9 potentiates the interleukin-4-induced immunoglobulin (IgG, IgM and IgE) production by normal human B lymphocytes","volume":"23","author":"Dugas","year":"1993","journal-title":"Eur J Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2016.02.020_bb0255","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/02770903.2011.554944","article-title":"Th9: a new player in asthma pathogenesis?","volume":"48","author":"Xing","year":"2011","journal-title":"J Asthma"},{"issue":"8","key":"10.1016\/j.autrev.2016.02.020_bb0260","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/nm.2856","article-title":"Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells","volume":"18","author":"Purwar","year":"2012","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.autrev.2016.02.020_bb0265","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1002\/eji.1830271011","article-title":"Interleukin-9 is involved in host protective immunity to intestinal nematode infection","volume":"27","author":"Faulkner","year":"1997","journal-title":"Eur J Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2016.02.020_bb0270","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1074-7613(00)00056-X","article-title":"IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development","volume":"13","author":"Townsend","year":"2000","journal-title":"Immunity"},{"issue":"7106","key":"10.1016\/j.autrev.2016.02.020_bb0275","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/nature05010","article-title":"Mast cells are essential intermediaries in regulatory T-cell tolerance","volume":"442","author":"Lu","year":"2006","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.autrev.2016.02.020_bb0280","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.cytogfr.2013.09.001","article-title":"Targeting T-helper 9 cells and interleukin-9 in autoimmune diseases","volume":"24","author":"Pan","year":"2013","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.autrev.2016.02.020_bb0285","doi-asserted-by":"crossref","first-page":"728610","DOI":"10.1155\/2015\/728610","article-title":"The role of citrullinated protein antibodies in predicting erosive disease in rheumatoid arthritis: a systematic literature review and meta-analysis","volume":"2015","author":"Jilani","year":"2015","journal-title":"Int J Rheumatol"},{"issue":"12","key":"10.1016\/j.autrev.2016.02.020_bb0290","first-page":"2336","article-title":"A distinct multicytokine profile is associated with anti-cyclical citrullinated peptide antibodies in patients with early untreated inflammatory arthritis","volume":"31","author":"Hitchon","year":"2004","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2016.02.020_bb0295","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/art.27186","article-title":"Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis","volume":"62","author":"Kokkonen","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.autrev.2016.02.020_bb0300","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1002\/art.27638","article-title":"The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age-dependent manner","volume":"62","author":"Deane","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2016.02.020_bb0305","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/cyto.b.20452","article-title":"A comparison of multiplex suspension array large-panel kits for profiling cytokines and chemokines in rheumatoid arthritis patients","volume":"76","author":"Khan","year":"2009","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.autrev.2016.02.020_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2015.08.260","article-title":"The role of cytokines in the pathogenesis of rheumatoid arthritis - Practical and potential application of cytokines as biomarkers and targets of personalized therapy","author":"Brzustewicz","year":"2015","journal-title":"Cytokine"},{"issue":"6","key":"10.1016\/j.autrev.2016.02.020_bb0315","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1136\/annrheumdis-2012-201505","article-title":"Multiple cytokines and chemokines are associated with rheumatoid arthritis-related autoimmunity in first-degree relatives without rheumatoid arthritis: Studies of the Aetiology of Rheumatoid Arthritis (SERA)","volume":"72","author":"Hughes-Austin","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.02.020_bb0320","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kev252","article-title":"Potential involvement of IL-9 and Th9 cells in the pathogenesis of rheumatoid arthritis","author":"Ciccia","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2016.02.020_bb0325","doi-asserted-by":"crossref","first-page":"519638","DOI":"10.1155\/2015\/519638","article-title":"Increased Serum Interleukin-9 Levels in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Pathogenic Role or Just an Epiphenomenon?","volume":"2015","author":"Dantas","year":"2015","journal-title":"Dis Markers"},{"issue":"1","key":"10.1016\/j.autrev.2016.02.020_bb0330","first-page":"28","article-title":"Potential roles of IL-9 in the pathogenesis of systemic lupus erythematosus","volume":"1","author":"Leng","year":"2012","journal-title":"Am J Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2016.02.020_bb0335","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2119\/molmed.2014.00237","article-title":"Interleukin-9 Is associated with elevated anti-double-stranded DNA antibodies in lupus-prone mice","volume":"21","author":"Yang","year":"2015","journal-title":"Mol Med"},{"issue":"3","key":"10.1016\/j.autrev.2016.02.020_bb0340","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.3892\/mmr.2013.1258","article-title":"Increased interleukin9 and CD4+ IL-9+ T cells in patients with systemic lupus erythematosus","volume":"7","author":"Ouyang","year":"2013","journal-title":"Mol Med Rep"},{"issue":"2","key":"10.1016\/j.autrev.2016.02.020_bb0345","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2567.2010.03332.x","article-title":"Interleukin-9 as a T helper type 17 cytokine","volume":"131","author":"Nowak","year":"2010","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.autrev.2016.02.020_bb0350","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.rdc.2008.01.001","article-title":"The pathology of scleroderma vascular disease","volume":"34","author":"Fleming","year":"2008","journal-title":"Rheum Dis Clin North Am"},{"issue":"2","key":"10.1016\/j.autrev.2016.02.020_bb0355","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.autrev.2010.08.003","article-title":"Relationship between cytokine profiles and clinical outcomes in patients with systemic sclerosis","volume":"10","author":"Baraut","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.autrev.2016.02.020_bb0360","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1365-2249.2004.02642.x","article-title":"Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement","volume":"138","author":"Scala","year":"2004","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"10.1016\/j.autrev.2016.02.020_bb0365","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.3899\/jrheum.110268","article-title":"Serum interleukin 9 levels are increased in patients with systemic sclerosis: association with lower frequency and severity of pulmonary fibrosis","volume":"38","author":"Yanaba","year":"2011","journal-title":"J Rheumatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997216300477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997216300477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T16:37:53Z","timestamp":1718383073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997216300477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":73,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S1568997216300477"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2016.02.020","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Th9 lymphocytes: A recent history from IL-9 to its potential role in rheumatic diseases","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2016.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}